Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy

Urology

Volumn 66, Issue 2, 2005, Pages 361-365

  Guzzo, Thomas J ^a   Vira, Manish ^b   Hwang, Wei Ting ^b   D'Amico, Anthony ^b   Tomaszewski, John ^b   Whittington, Richard ^b   Wein, Alan J ^b   Vanarsdalen, Keith ^b   Malkowicz, S Bruce ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; DATA BASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEEDLE BIOPSY; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRATIFICATION; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY; TUMOR VOLUME;

ADENOCARCINOMA; BIOPSY; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS;

EID: 23744507037     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.02.029     Document Type: Article

References (15)

1. Y. Lotan, S.F. Shariat, S.M. Khoddami The percent of biopsy cores positive for cancer is a predictor of advanced pathologic stage and poor clinical outcomes in patients treated with radical prostatectomy J Urol 171 2004 2209 2214
2. M.H. Winkler, E. Kulinskaya, D.A. Gillatt Prediction of prostate cancer in extended field biopsies of the prostate BJU Int 93 2004 516 521
3. K. Cam, S. Yucel, L. Turkeri Accuracy of transrectal ultrasound guided prostate biopsy histopathological correlation to matched prostatectomy specimens Int J Urol 9 2002 257 260
4. T.J. Sebo, J.C. Cheville, D.L. Riehle Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen a report of 454 cases Cancer 91 2001 2196 2204
5. H.B. Carter, J. Sauvageot, P.C. Walsh Prospective evaluation of men with stage T1c adenocarcinoma of the prostate J Urol 157 1997 2206 2209
6. R.F. Hoedemaeker, T.H. Van der Kwast, F.H. Schroder The clinical significance of a small focus of well-differentiated carcinoma at prostate biopsy BJU Int 92 2003 92 95
7. M. Noguchi, T.A. Stamey, J.E. McNeal Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens lack of prediction of tumor significance for men with nonpalpable prostate cancer J Urol 166 2001 104 110
8. R.W. Allan, H. Sanderson, J.I. Epstein Correlation of minute (0.5 mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen role of prostate specific antigen density J Urol 170 2003 370 372
9. D.J. Grossklaus, C.S. Coffey, S.B. Shapell Percent of cancer in the biopsy set predicts pathological findings after prostatectomy J Urol 167 2002 2032 2035
10. A.W. Partin, J.I. Epstein, K.R. Cho Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage and clinical stage in clinical stage B prostate cancer J Urol 141 1989 341 345
11. J.I. Epstein, S.R. Potter The pathological interpretation and significance of prostate needle biopsy findings implications and current controversies J Urol 166 2001 402 410
12. M.L. Wills, J. Sauvageot, A.W. Partin Ability of sextant biopsies to predict radical prostatectomy stage Urology 51 1998 759 764
13. J.I. Epstein, P.C. Walsh, C.B. Brendler Radical prostatectomy for impalpable prostate cancer the Johns Hopkins experience with tumors found on transurethral resection (T1a and T1b) and on needle biopsy (T1c) J Urol 152 1994 1721 1729
14. Y. Goto, M. Ohori, A. Arakawa Distinguishing clinically important from unimportant prostate cancers before treatment value of systematic biopsies J Urol 156 1996 1059 1063
15. D.S. DiMarco, M.L. Blute, H. Zincke Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ confined disease and needle biopsy Gleason score of 6 or less Urol Oncol 21 2003 439 446